Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 153 articles:
HTML format
Text format



Single Articles


    June 2018
  1. LEE AR, Lim KH, Park ES, Kim DH, et al
    Multiple functions of c-FLIP are essential for replication of hepatitis B virus.
    J Virol. 2018 Jun 6. pii: JVI.00339-18. doi: 10.1128/JVI.00339.
    PubMed     Text format     Abstract available


    May 2018
  2. ABDUL F, Filleton F, Gerossier L, Paturel A, et al
    Smc5/6 Antagonism by HBx Is an Evolutionarily Conserved Function of Hepatitis B Virus Infection in Mammals.
    J Virol. 2018 May 30. pii: JVI.00769-18. doi: 10.1128/JVI.00769.
    PubMed     Text format     Abstract available


  3. LEE J, Zong L, Krotow A, Qin Y, et al
    N-linked glycosylation is not essential for sodium taurocholate cotransporting polypeptide to mediate hepatitis B virus infection in vitro.
    J Virol. 2018 May 23. pii: JVI.00732-18. doi: 10.1128/JVI.00732.
    PubMed     Text format     Abstract available


  4. BELOUZARD S, Danneels A, Feneant L, Seron K, et al
    Correction for Belouzard et al., "Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes".
    J Virol. 2018;92.
    PubMed     Text format    


  5. FREITAS N, Lukash T, Gunewardena S, Chappell B, et al
    Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  6. NAIR S, Zlotnick A
    Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  7. NING X, Luckenbaugh L, Liu K, Bruss V, et al
    Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-free Hepatitis B Virions.
    J Virol. 2018 May 9. pii: JVI.00272-18. doi: 10.1128/JVI.00272.
    PubMed     Text format     Abstract available


    April 2018
  8. KIM JY, Ou JJ
    Regulation of Apolipoprotein E Trafficking by Hepatitis C Virus-induced Autophagy.
    J Virol. 2018 Apr 25. pii: JVI.00211-18. doi: 10.1128/JVI.00211.
    PubMed     Text format     Abstract available


  9. DE OLIVEIRA CARNEIRO I, Sander AL, Silva N, Moreira-Soto A, et al
    A novel marsupial hepatitis A virus corroborates complex evolutionary patterns shaping the genus Hepatovirus.
    J Virol. 2018 Apr 25. pii: JVI.00082-18. doi: 10.1128/JVI.00082.
    PubMed     Text format     Abstract available


  10. MATSUI C, Deng L, Minami N, Abe T, et al
    Hepatitis C virus NS5A protein promotes the lysosomal degradation of hepatocyte nuclear factor 1alpha via chaperone-mediated autophagy.
    J Virol. 2018 Apr 25. pii: JVI.00639-18. doi: 10.1128/JVI.00639.
    PubMed     Text format     Abstract available


  11. KARIMZADEH H, Kiraithe MM, Kosinska AD, Glaser M, et al
    Amino acid substitutions within HLA-B*27-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8+ T cells.
    J Virol. 2018 Apr 18. pii: JVI.01891-17. doi: 10.1128/JVI.01891.
    PubMed     Text format     Abstract available


  12. CHEN Y, Liu B, Sun Y, Li H, et al
    Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.
    J Virol. 2018 Apr 18. pii: JVI.00251-18. doi: 10.1128/JVI.00251.
    PubMed     Text format     Abstract available


  13. ZHAO Q, Hu Z, Cheng J, Wu S, et al
    Hepatitis B virus core protein dephosphorylation occurs during pregenomic RNA encapsidation.
    J Virol. 2018 Apr 18. pii: JVI.02139-17. doi: 10.1128/JVI.02139.
    PubMed     Text format     Abstract available


  14. IQBAL J, Sarkar-Dutta M, McRae S, Ramachandran A, et al
    Osteopontin regulates HCV replication and assembly via interaction with HCV proteins and lipid droplets and by binding to receptors, alphaVbeta3 and CD44.
    J Virol. 2018 Apr 18. pii: JVI.02116-17. doi: 10.1128/JVI.02116.
    PubMed     Text format     Abstract available


    March 2018
  15. AUNINS TR, Marsh KA, Subramanya G, Uprichard SL, et al
    Intracellular hepatitis C modeling predicts infection dynamics and viral protein mechanisms.
    J Virol. 2018 Mar 21. pii: JVI.02098-17. doi: 10.1128/JVI.02098.
    PubMed     Text format     Abstract available


  16. NGUYEN TT, Park EM, Lim YS, Hwang SB, et al
    Nonstructural 5A impairs DNA damage repair: Implication of hepatitis C virus-mediated hepatocarcinogenesis.
    J Virol. 2018 Mar 21. pii: JVI.00178-18. doi: 10.1128/JVI.00178.
    PubMed     Text format     Abstract available


  17. NISHITSUJI H, Ujino S, Harada K, Shimotohno K, et al
    TIP60 Complex Inhibits Hepatitis B Virus Transcription.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  18. HALDIPUR B, Bhukya PL, Arankalle V, Lole K, et al
    Positive regulation of hepatitis E virus replication by microRNA-122.
    J Virol. 2018 Mar 14. pii: JVI.01999-17. doi: 10.1128/JVI.01999.
    PubMed     Text format     Abstract available


  19. LAW JLM, Logan M, Wong J, Kundu J, et al
    Role of the E2 hypervariable region (HVR1) in the immunogenicity of a recombinant HCV vaccine.
    J Virol. 2018 Mar 14. pii: JVI.02141-17. doi: 10.1128/JVI.02141.
    PubMed     Text format     Abstract available


  20. SUFFNER S, Gerstenberg N, Patra M, Ruibal P, et al
    Domains of the hepatitis B virus small surface protein S mediating oligomerization.
    J Virol. 2018 Mar 14. pii: JVI.02232-17. doi: 10.1128/JVI.02232.
    PubMed     Text format     Abstract available


    February 2018
  21. RIVA L, Song OR, Prentoe J, Helle F, et al
    IDENTIFICATION OF PIPERAZINYLBENZENESULFONAMIDES AS NEW INHIBITORS OF CLAUDIN-1 TRAFFICKING AND HEPATITIS C VIRUS ENTRY.
    J Virol. 2018 Feb 28. pii: JVI.01982-17. doi: 10.1128/JVI.01982.
    PubMed     Text format     Abstract available


  22. GU J, Hardy J, Boo I, Vietheer P, et al
    Escape of Hepatitis C virus from epitope I neutralization increases sensitivity of other neutralization epitopes.
    J Virol. 2018 Feb 21. pii: JVI.02066-17. doi: 10.1128/JVI.02066.
    PubMed     Text format     Abstract available


  23. MOUSTAFA S, Karakasiliotis I, Mavromara P
    Hepatitis C virus core+1/ARFP modulates Cyclin D1/pRb pathway and promotes carcinogenesis.
    J Virol. 2018 Feb 14. pii: JVI.02036-17. doi: 10.1128/JVI.02036.
    PubMed     Text format     Abstract available


  24. COSTAFREDA MI, Kaplan G
    HAVCR1 (CD365) and its mouse ortholog are functional hepatitis A virus (HAV) cellular receptors that mediate HAV infection.
    J Virol. 2018 Feb 7. pii: JVI.02065-17. doi: 10.1128/JVI.02065.
    PubMed     Text format     Abstract available


  25. SHIMIZU Y, Shirasago Y, Kondoh M, Suzuki T, et al
    Monoclonal antibodies against occludin completely prevented hepatitis C virus infection in a mouse model.
    J Virol. 2018 Feb 7. pii: JVI.02258-17. doi: 10.1128/JVI.02258.
    PubMed     Text format     Abstract available


  26. WIJESUNDARA DK, Gummow J, Li Y, Yu W, et al
    Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice.
    J Virol. 2018 Feb 7. pii: JVI.02133-17. doi: 10.1128/JVI.02133.
    PubMed     Text format     Abstract available


  27. TU T, Budzinska MA, Vondran FWR, Shackel NA, et al
    Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via NTCP-dependent uptake of enveloped virus particles.
    J Virol. 2018 Feb 7. pii: JVI.02007-17. doi: 10.1128/JVI.02007.
    PubMed     Text format     Abstract available


  28. SONG M, Sun Y, Tian J, He W, et al
    Silencing Retinoid X Receptor Alpha Expression Enhances Early-stage Hepatitis B Virus Infection In Cell Cultures.
    J Virol. 2018 Feb 7. pii: JVI.01771-17. doi: 10.1128/JVI.01771.
    PubMed     Text format     Abstract available


  29. WONDERLICH ER, Caroline AL, McMillen CM, Walters AW, et al
    Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    January 2018
  30. LI Q, Tong Y, Xu Y, Niu J, et al
    Genetic Analysis of Serum-derived HCV Defective Genomes Revealed Novel Viral Cis-Elements for Virus Replication and Assembly.
    J Virol. 2018 Jan 24. pii: JVI.02182-17. doi: 10.1128/JVI.02182.
    PubMed     Text format     Abstract available


  31. DORING T, Zeyen L, Bartusch C, Prange R, et al
    Hepatitis B Virus Subverts the Autophagy Elongation Complex Atg5-12/16L1 and Does not Require Atg8/LC3 Lipidation for Viral Maturation.
    J Virol. 2018 Jan 24. pii: JVI.01513-17. doi: 10.1128/JVI.01513.
    PubMed     Text format     Abstract available


  32. YI G, Wen Y, Shu C, Han Q, et al
    Correction for Yi et al., "Hepatitis C Virus NS4B Can Suppress STING Accumulation To Evade Innate Immune Responses".
    J Virol. 2018;92.
    PubMed     Text format    


  33. DUAN X, Li S, Holmes JA, Tu Z, et al
    MicroRNA-130a regulates both HCV and HBV replication through a central metabolic pathway.
    J Virol. 2018 Jan 10. pii: JVI.02009-17. doi: 10.1128/JVI.02009.
    PubMed     Text format     Abstract available


  34. KANADE GD, Pingale KD, Karpe YA
    Activities of Thrombin and Factor Xa are essential for replication of Hepatitis E virus and are possibly implicated in the ORF1 polyprotein processing.
    J Virol. 2018 Jan 10. pii: JVI.01853-17. doi: 10.1128/JVI.01853.
    PubMed     Text format     Abstract available


  35. KACHKO A, Costafreda MI, Zubkova I, Jacques J, et al
    Determinants in the IgV Domain of human HAVCR1 (TIM-1) are required to enhance Hepatitis C Virus Entry.
    J Virol. 2018 Jan 10. pii: JVI.01742-17. doi: 10.1128/JVI.01742.
    PubMed     Text format     Abstract available


    December 2017
  36. KWEI K, Tang X, Lok AS, Sureau C, et al
    Correction for Kwei et al., "Impaired Virion Secretion by Hepatitis B Virus Immune Escape Mutants and Its Rescue by Wild-Type Envelope Proteins or a Second-Site Mutation".
    J Virol. 2017;91.
    PubMed     Text format    


  37. YANG Z, Wang X, Chi X, Zhao F, et al
    Correction for Yang et al., "Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection".
    J Virol. 2017;91.
    PubMed     Text format    


  38. KIM H, Bose SK, Meyer K, Ray R, et al
    Correction for Kim et al., "Hepatitis C Virus Impairs Natural Killer Cell-Mediated Augmentation of Complement Synthesis".
    J Virol. 2017;91.
    PubMed     Text format    


  39. BEILSTEIN F, Blanchet M, Vaillant A, Sureau C, et al
    Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.
    J Virol. 2017 Dec 6. pii: JVI.01416-17. doi: 10.1128/JVI.01416.
    PubMed     Text format     Abstract available


  40. DIXIT U, Pandey AK, Liu Z, Kumar S, et al
    Correction for Dixit et al., "FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53".
    J Virol. 2017;91.
    PubMed     Text format    


    November 2017
  41. PAUL D, Madan V, Ramirez O, Bencun M, et al
    Glycine-zipper motifs in hepatitis C virus nonstructural protein 4B are required for the establishment of viral replication organelles.
    J Virol. 2017 Nov 22. pii: JVI.01890-17. doi: 10.1128/JVI.01890.
    PubMed     Text format     Abstract available


  42. AGARWAL S, Baccam P, Aggarwal R, Veerapu NS, et al
    Novel Synthesis and Phenotypic Analysis of Mutant Clouds for Hepatitis E Virus Genotype 1.
    J Virol. 2017 Nov 22. pii: JVI.01932-17. doi: 10.1128/JVI.01932.
    PubMed     Text format     Abstract available


  43. SKARDASI G, Chen AY, Michalak TI
    Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4+ and CD8+ T Lymphocytes In Vitro.
    J Virol. 2017 Nov 22. pii: JVI.01790-17. doi: 10.1128/JVI.01790.
    PubMed     Text format     Abstract available


  44. SCHWEITZER CJ, Zhang F, Boyer A, Valdez K, et al
    N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.
    J Virol. 2017 Nov 8. pii: JVI.01166-17. doi: 10.1128/JVI.01166.
    PubMed     Text format     Abstract available


  45. MORENO-CUBERO E, Subira D, Sanz-de-Villalobos E, Parra-Cid T, et al
    According to HCV infection stage, IL-7 plus 4-1BB triggering alone or combined with PD-1 blockade increases TRAF1low HCV-specific CD8+ cell reactivity.
    J Virol. 2017 Nov 1. pii: JVI.01443-17. doi: 10.1128/JVI.01443.
    PubMed     Text format     Abstract available


  46. BRAHMS A, Mudhasani R, Pinkham C, Kota K, et al
    Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    October 2017
  47. ZHOU T, Ren X, Adams RL, Pyle AM, et al
    NS3 from HCV strain JFH-1 is an unusually robust helicase that is primed to bind and unwind viral RNA.
    J Virol. 2017 Oct 25. pii: JVI.01253-17. doi: 10.1128/JVI.01253.
    PubMed     Text format     Abstract available


  48. STOECK IK, Lee JY, Tabata K, Romero-Brey I, et al
    Hepatitis C virus replication depends on endosomal cholesterol homeostasis.
    J Virol. 2017 Oct 18. pii: JVI.01196-17. doi: 10.1128/JVI.01196.
    PubMed     Text format     Abstract available


  49. CASE JB, Li Y, Elliott R, Lu X, et al
    Murine hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity.
    J Virol. 2017 Oct 18. pii: JVI.01531-17. doi: 10.1128/JVI.01531.
    PubMed     Text format     Abstract available


  50. LI M, Sohn JA, Seeger C
    Distribution of hepatitis B virus nuclear DNA.
    J Virol. 2017 Oct 18. pii: JVI.01391-17. doi: 10.1128/JVI.01391.
    PubMed     Text format     Abstract available


    September 2017
  51. QIN Y, Xue B, Liu C, Wang X, et al
    NLRX1 mediates MAVS degradation to attenuate hepatitis C virus-induced innate immune response through PCBP2.
    J Virol. 2017 Sep 27. pii: JVI.01264-17. doi: 10.1128/JVI.01264.
    PubMed     Text format     Abstract available


  52. FAUTEUX-DANIEL S, Larouche A, Calderon V, Boulais J, et al
    Vertical transmission of hepatitis C virus: variable transmission bottleneck and evidence of mid-gestation in utero infection.
    J Virol. 2017 Sep 20. pii: JVI.01372-17. doi: 10.1128/JVI.01372.
    PubMed     Text format     Abstract available


  53. NAGASHIMA S, Takahashi M, Kobayashi T, Tanggis, et al
    The characterization of the quasi-enveloped hepatitis E virus particles released by the cellular exosomal pathway.
    J Virol. 2017 Sep 6. pii: JVI.00822-17. doi: 10.1128/JVI.00822.
    PubMed     Text format     Abstract available


    August 2017
  54. KAUSHIK N, Subramani C, Anang S, Muthumohan R, et al
    Zinc salts block Hepatitis E virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase.
    J Virol. 2017 Aug 16. pii: JVI.00754-17. doi: 10.1128/JVI.00754.
    PubMed     Text format     Abstract available


  55. LIU N, Zhang J, Yang X, Jiao T, et al
    HDM2 Promotes NEDDylation of Hepatitis B Virus HBx To Enhance Its Stability and Function.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  56. KWON YC, Sasaki R, Meyer K, Ray R, et al
    HEPATITIS C VIRUS CORE PROTEIN MODULATES ENDOGLIN (CD105) SIGNALING PATHWAY FOR LIVER PATHOGENESIS.
    J Virol. 2017 Aug 9. pii: JVI.01235-17. doi: 10.1128/JVI.01235.
    PubMed     Text format     Abstract available


  57. PIERCE BG, Boucher EN, Piepenbrink KH, Ejemel M, et al
    Structure-Based Design of Hepatitis C Virus Vaccines that Elicit Neutralizing Antibody Responses to a Conserved Epitope.
    J Virol. 2017 Aug 9. pii: JVI.01032-17. doi: 10.1128/JVI.01032.
    PubMed     Text format     Abstract available


  58. SHALABY RE, Iram S, Cakal B, Oropeza CE, et al
    PGC1alpha TRANSCRIPTIONAL ADAPTOR FUNCTION GOVERNS HEPATITIS B VIRUS REPLICATION BY CONTROLLING HBcAg/p21 PROTEIN MEDIATED CAPSID FORMATION.
    J Virol. 2017 Aug 2. pii: JVI.00790-17. doi: 10.1128/JVI.00790.
    PubMed     Text format     Abstract available


  59. ZHONG L, Shu W, Dai W, Gao B, et al
    Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    July 2017
  60. KIM JY, Wang L, Lee J, Ou JJ, et al
    HCV induces the localization of lipid rafts to autophagosomes for its RNA replication.
    J Virol. 2017 Jul 26. pii: JVI.00541-17. doi: 10.1128/JVI.00541.
    PubMed     Text format     Abstract available


  61. SOORYANARAIN H, Rogers AJ, Cao D, Haac MER, et al
    ISG15 modulates type-I interferon signaling and antiviral response during hepatitis E virus replication.
    J Virol. 2017 Jul 19. pii: JVI.00621-17. doi: 10.1128/JVI.00621.
    PubMed     Text format     Abstract available


  62. YIN P, Li Y, Zhang L
    Sec24C-Dependent Transport of Claudin-1 Regulates Hepatitis C Virus Entry.
    J Virol. 2017 Jul 5. pii: JVI.00629-17. doi: 10.1128/JVI.00629.
    PubMed     Text format     Abstract available


    June 2017
  63. WELLER R, Hueging K, Brown RJP, Todt D, et al
    Hepatitis C virus strain-dependent usage of apolipoprotein E modulates assembly efficiency and specific infectivity of secreted virions.
    J Virol. 2017 Jun 28. pii: JVI.00422-17. doi: 10.1128/JVI.00422.
    PubMed     Text format     Abstract available


  64. BELOUZARD S, Danneels A, Feneant L, Seron K, et al
    Entry and release of hepatitis C virus in polarized human hepatocytes.
    J Virol. 2017 Jun 28. pii: JVI.00478-17. doi: 10.1128/JVI.00478.
    PubMed     Text format     Abstract available


  65. CEVIK RE, Cesarec M, Da Silva Filipe A, Licastro D, et al
    Hepatitis C virus NS5A targets the nucleosome assembly protein NAP1L1 to control the innate cellular response.
    J Virol. 2017 Jun 28. pii: JVI.00880-17. doi: 10.1128/JVI.00880.
    PubMed     Text format     Abstract available


  66. LUO J, Cui X, Gao L, Hu J, et al
    Identification of Intermediate in Hepatitis B Virus CCC DNA Formation and Sensitive and Selective CCC DNA Detection.
    J Virol. 2017 Jun 21. pii: JVI.00539-17. doi: 10.1128/JVI.00539.
    PubMed     Text format     Abstract available


  67. GOONAWARDANE N, Gebhardt A, Bartlett C, Pichlmair A, et al
    Phosphorylation of serine 225 in hepatitis C virus NS5A regulates protein-protein interactions.
    J Virol. 2017 Jun 14. pii: JVI.00805-17. doi: 10.1128/JVI.00805.
    PubMed     Text format     Abstract available


    May 2017
  68. WONG MT, Chen SS
    Hepatitis C Virus Subverts Human Choline Kinase-alpha to Bridge PI4KIIIalpha and NS5A and Upregulates PI4KIIIalpha Activation, Thereby Promoting the Translocation of the Ternary Complex to the ER for Viral Replication.
    J Virol. 2017 May 31. pii: JVI.00355-17. doi: 10.1128/JVI.00355.
    PubMed     Text format     Abstract available


  69. WU S, Zhao Q, Zhang P, Kulp J, et al
    Discovery and mechanistic study of benzamide derivatives that modulate hepatitis B virus capsid assembly.
    J Virol. 2017 May 31. pii: JVI.00519-17. doi: 10.1128/JVI.00519.
    PubMed     Text format     Abstract available


  70. LI Z, Li Y, Bi Y, Zhang H, et al
    Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.
    J Virol. 2017 May 24. pii: JVI.02227-16. doi: 10.1128/JVI.02227.
    PubMed     Text format     Abstract available


  71. SYED GH, Khan M, Yang S, Siddiqui A, et al
    Hepatitis C virus lipoviroparticles (HCV-LVP) assemble in the endoplasmic reticulum (ER) and bud off from the ER to Golgi in COPII vesicles.
    J Virol. 2017 May 17. pii: JVI.00499-17. doi: 10.1128/JVI.00499.
    PubMed     Text format     Abstract available


  72. DEVHARE PB, Sasaki R, Shrivastava S, Di Bisceglie AM, et al
    Correction for Devhare et al., "Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells".
    J Virol. 2017;91.
    PubMed     Text format    


    April 2017
  73. FILSKOV J, Mikkelsen M, Hansen PR, Christensen JP, et al
    Broadening CD4+ and CD8+ T cell responses against hepatitis C virus by vaccination with NS3 overlapping peptide panels in cross-priming liposomes.
    J Virol. 2017 Apr 26. pii: JVI.00130-17. doi: 10.1128/JVI.00130.
    PubMed     Text format     Abstract available


  74. HSU SC, Lo CW, Pan TC, Lee KY, et al
    Serine 235 Is the Primary NS5A Hyper-Phosphorylation Site Responsible for HCV Replication.
    J Virol. 2017 Apr 26. pii: JVI.00194-17. doi: 10.1128/JVI.00194.
    PubMed     Text format     Abstract available


  75. FAN H, Qiao L, Kang KD, Fan J, et al
    Attachment and Post-Attachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.
    J Virol. 2017 Apr 12. pii: JVI.00280-17. doi: 10.1128/JVI.00280.
    PubMed     Text format     Abstract available


    March 2017
  76. MORENO E, Gallego I, Gregori J, Lucia-Sanz A, et al
    Internal disequilibria and phenotypic diversification during replication of hepatitis C virus in a non-coevolving cellular environment.
    J Virol. 2017 Mar 8. pii: JVI.02505-16. doi: 10.1128/JVI.02505.
    PubMed     Text format     Abstract available


  77. OJIRO K, Qu X, Cho H, Park JJ, et al
    Modulation of HCV-specific CD8 effector T-cell function with antiviral effect in infectious hepatitis C virus co-culture model.
    J Virol. 2017 Mar 8. pii: JVI.02129-16. doi: 10.1128/JVI.02129.
    PubMed     Text format     Abstract available


    February 2017
  78. BALASIDDAIAH A, Davanian H, Aleman S, Pasetto A, et al
    Hepatitis C Virus-Specific T Cell Receptor mRNA-engineered Human T Cells: Impact of Antigen-Specificity on Functional Properties.
    J Virol. 2017 Feb 22. pii: JVI.00010-17. doi: 10.1128/JVI.00010.
    PubMed     Text format     Abstract available


  79. BRAYNE AB, Dearlove BL, Lester JS, Kosakovsky Pond SL, et al
    Genotype-specific evolution of hepatitis E virus.
    J Virol. 2017 Feb 15. pii: JVI.02241-16. doi: 10.1128/JVI.02241.
    PubMed     Text format     Abstract available


  80. HADDAD J, Rouille Y, Hanoulle X, Descamps V, et al
    Identification of novel functions for hepatitis C virus envelope glycoprotein E1 in virus entry and assembly.
    J Virol. 2017 Feb 8. pii: JVI.00048-17. doi: 10.1128/JVI.00048.
    PubMed     Text format     Abstract available


  81. FREEDMAN H, Logan MR, Hockman D, Leman JK, et al
    Computational prediction of the heterodimeric and higher order structure of gpE1/gpE2 envelope glycoproteins encoded by the hepatitis C virus (HCV).
    J Virol. 2017 Feb 1. pii: JVI.02309-16. doi: 10.1128/JVI.02309.
    PubMed     Text format     Abstract available


  82. YANG X, Li H, Sun H, Fan H, et al
    Hepatitis B virus-encoded miRNA controls viral replication.
    J Virol. 2017 Feb 1. pii: JVI.01919-16. doi: 10.1128/JVI.01919.
    PubMed     Text format     Abstract available


    January 2017
  83. CHEN J, Xu W, Chen Y, Xie X, et al
    MMP-9 Facilitates Hepatitis B Virus Replication through Binding with IFNAR1 to Repress IFN/JAK/STAT Signaling.
    J Virol. 2017 Jan 25. pii: JVI.01824-16. doi: 10.1128/JVI.01824.
    PubMed     Text format     Abstract available


  84. TONG Y, Chi X, Yang W, Zhong J, et al
    Functional analysis of HCV envelope protein E1 using a trans-complementation system reveals a dual role of a putative fusion peptide of E1 in both HCV entry and morphogenesis.
    J Virol. 2017 Jan 18. pii: JVI.02468-16. doi: 10.1128/JVI.02468.
    PubMed     Text format     Abstract available


  85. DEVHARE PB, Sasaki R, Shrivastava S, Di Bisceglie AM, et al
    Exosome mediated intercellular communication between hepatitis C virus infected hepatocytes and hepatic stellate cells.
    J Virol. 2017 Jan 11. pii: JVI.02225-16. doi: 10.1128/JVI.02225.
    PubMed     Text format     Abstract available


  86. HO CK, Raghwani J, Koekkoek S, Liang RH, et al
    Characterization of HCV envelope diversification from acute to chronic infection using SMRT sequencing within a sexually-transmitted hepatitis C virus cluster.
    J Virol. 2017 Jan 11. pii: JVI.02262-16. doi: 10.1128/JVI.02262.
    PubMed     Text format     Abstract available


  87. YAN Y, He Y, Boson B, Wang X, et al
    A point mutation in the N-terminal amphiphathic helix alpha0 in NS3 promotes HCV assembly by altering core localization to ER and facilitating virus budding.
    J Virol. 2017 Jan 4. pii: JVI.02399-16. doi: 10.1128/JVI.02399.
    PubMed     Text format     Abstract available


  88. WALTER S, Rasche A, Moreira-Soto A, Pfaender S, et al
    Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys.
    J Virol. 2016;91.
    PubMed     Text format     Abstract available


    December 2016
  89. MCCAFFREY K, Boo I, Owczarek CM, Hardy MP, et al
    An optimized hepatitis C virus E2 glycoprotein core adopts a functional homodimer that efficiently blocks virus entry.
    J Virol. 2016 Dec 28. pii: JVI.01668-16. doi: 10.1128/JVI.01668.
    PubMed     Text format     Abstract available


  90. DING Q, von Schaewen M, Hrebikova G, Heller B, et al
    Mice expressing minimally humanized CD81 and occludin genes support hepatitis C virus uptake in vivo.
    J Virol. 2016 Dec 7. pii: JVI.01799.
    PubMed     Text format     Abstract available


  91. MURAYAMA A, Sugiyama N, Suzuki R, Moriyama M, et al
    Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    J Virol. 2016 Dec 7. pii: JVI.02124.
    PubMed     Text format     Abstract available


    November 2016
  92. CLARK DN, Flanagan JM, Hu J
    Mapping of Functional Subdomains in Terminal Protein Domain of Hepatitis B Virus Polymerase.
    J Virol. 2016 Nov 16. pii: JVI.01785.
    PubMed     Text format     Abstract available


  93. PHAM TM, Tran SC, Lim YS, Hwang SB, et al
    Hepatitis C Virus-Induced Rab32 Aggregation and its Implication in Virion Assembly.
    J Virol. 2016 Nov 16. pii: JVI.01662.
    PubMed     Text format     Abstract available


  94. ZHAO F, Zhao T, Deng L, Lv D, et al
    Visualizing the essential role of complete virion assembly machinery in efficient hepatitis C virus cell-to-cell transmission by viral infection activated split-intein mediated reporter system (VISI).
    J Virol. 2016 Nov 16. pii: JVI.01720.
    PubMed     Text format     Abstract available


  95. PIETSCHMANN T
    Clinically approved ion channel inhibitors close gates for hepatitis C virus -and open doors for drug repurposing in viral infectious diseases.
    J Virol. 2016 Nov 2. pii: JVI.01914.
    PubMed     Text format     Abstract available


  96. WANG J, Qiao L, Hou Z, Luo G, et al
    TIM-1 promotes hepatitis C virus cell attachment and infection.
    J Virol. 2016 Nov 2. pii: JVI.01583.
    PubMed     Text format     Abstract available


    October 2016
  97. LOGAN M, Law J, Wong JA, Hockman D, et al
    Native folding of a recombinant gpE1/gpE2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG.
    J Virol. 2016 Oct 19. pii: JVI.01552.
    PubMed     Text format     Abstract available


  98. ELGNER F, Ren H, Medvedev R, Ploen D, et al
    The intra-cellular cholesterol transport inhibitor U18666A inhibits the exosome-dependent release of mature hepatitis C virus.
    J Virol. 2016 Oct 5. pii: JVI.01053.
    PubMed     Text format     Abstract available


    September 2016
  99. CHAN ST, Lee J, Narula M, Ou JJ, et al
    Suppression of Host Innate Immune Response by Hepatitis C Virus via the Induction of Autophagic Degradation of TRAF6.
    J Virol. 2016 Sep 28. pii: JVI.01365.
    PubMed     Text format     Abstract available


  100. BAYER K, Banning C, Bruss V, Wiltzer-Bach L, et al
    Hepatitis C virus is released via a non-canonical secretory route.
    J Virol. 2016 Sep 14. pii: JVI.01615.
    PubMed     Text format     Abstract available


  101. LI D, von Schaewen M, Wang X, Tao W, et al
    Altered glycosylation patterns increase immunogenicity of a subunit HCV vaccine inducing neutralizing antibodies which confer protection in mice.
    J Virol. 2016 Sep 14. pii: JVI.01462.
    PubMed     Text format     Abstract available


  102. ZUIANI A, Chen K, Schwarz MC, White JP, et al
    An E2 gene infectious HCV library reveals growth adaptive mutations that modulate interactions with the scavenger receptor class B type I.
    J Virol. 2016 Sep 14. pii: JVI.01011.
    PubMed     Text format     Abstract available


    August 2016
  103. YI Z, Fang C, Zou J, Xu J, et al
    Affinity purification of the Hepatitis C virus replicase identifies Valosin-containing protein (VCP) AAA+ATPase as an active viral replication modulator.
    J Virol. 2016 Aug 24. pii: JVI.01140.
    PubMed     Text format     Abstract available


  104. YANG Z, Wang X, Chi X, Zhao F, et al
    Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.
    J Virol. 2016 Aug 17. pii: JVI.01353.
    PubMed     Text format     Abstract available


  105. KIM W, Lee S, Son Y, Ko C, et al
    DDB1 stimulates the viral transcription of hepatitis B virus via HBx-independent mechanisms.
    J Virol. 2016 Aug 17. pii: JVI.00977.
    PubMed     Text format     Abstract available


  106. SOZZI V, Walsh R, Littlejohn M, Colledge D, et al
    In vitro studies show that sequence variability contributes to marked variation in Hepatitis B virus replication, protein expression and function observed across genotypes.
    J Virol. 2016 Aug 10. pii: JVI.01293.
    PubMed     Text format     Abstract available


  107. WONG MT, Chen SS
    Human Choline Kinase-alpha Promotes Hepatitis C Virus RNA Replication through Modulating Membranous Viral Replication Complex Formation.
    J Virol. 2016 Aug 3. pii: JVI.00960.
    PubMed     Text format     Abstract available


  108. NAKAJIMA S, Watashi K, Ohashi H, Kamisuki S, et al
    Fungal-derived neoechinulin B as a novel antagonist of liver X receptor, identified by chemical genetics using hepatitis C virus cell culture system.
    J Virol. 2016 Aug 3. pii: JVI.00856.
    PubMed     Text format     Abstract available


  109. BLEAU C, Filliol A, Samson M, Lamontagne L, et al
    MOUSE HEPATITIS VIRUS INFECTION INDUCES A TLR2-DEPENDENT ACTIVATION OF INFLAMMATORY FUNCTIONS IN LIVER SINUSOIDAL ENDOTHELIAL CELLS DURING ACUTE HEPATITIS.
    J Virol. 2016 Aug 3. pii: JVI.01069.
    PubMed     Text format     Abstract available


    July 2016
  110. HE W, Cao Z, Mao F, Ren B, et al
    Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.
    J Virol. 2016 Jul 27. pii: JVI.00901.
    PubMed     Text format     Abstract available


  111. PUIG-BASAGOITI F, Fukuhara T, Tamura T, Ono C, et al
    Human cathelicidin compensates for the role of apolipoproteins in the infectious particle formation of HCV.
    J Virol. 2016 Jul 20. pii: JVI.00471.
    PubMed     Text format     Abstract available


  112. UNCHWANIWALA N, Sherer NM, Loeb DD
    Hepatitis B virus polymerase localizes to the mitochondria and its terminal protein domain contains the mitochondrial-targeting signal.
    J Virol. 2016 Jul 20. pii: JVI.01229.
    PubMed     Text format     Abstract available


  113. DI SCALA M, Otano I, Gil-Farina I, Vanrell L, et al
    Complementary effects of IL-15 and IFN-alpha induce immunity in HBV transgenic mice.
    J Virol. 2016 Jul 20. pii: JVI.01030.
    PubMed     Text format     Abstract available


  114. VAUSSELIN T, Seron K, Lavie M, Mesalam AA, et al
    Identification of a new benzimidazole derivative as an antiviral against hepatitis C virus.
    J Virol. 2016 Jul 13. pii: JVI.00404.
    PubMed     Text format     Abstract available


  115. LI J, Zong L, Sureau C, Barker L, et al
    UNUSUAL FEATURES OF SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE AS A HEPATITIS B VIRUS RECEPTOR.
    J Virol. 2016 Jul 6. pii: JVI.01153.
    PubMed     Text format     Abstract available


  116. ZHU S, Li T, Liu B, Xu Y, et al
    Infection of common marmosets with GB virus B chimeric virus encoding for the major nonstructural proteins NS2-4A of hepatitis C virus.
    J Virol. 2016 Jul 6. pii: JVI.02653.
    PubMed     Text format     Abstract available


    June 2016
  117. COLMAN H, Berre-Scoul CL, Hernandez C, Pierredon S, et al
    Correction for Colman et al., Genome-Wide Analysis of Host mRNA Translation during Hepatitis C Virus Infection.
    J Virol. 2016;90:5846.
    PubMed     Text format    


  118. MACPARLAND SA, Ma XZ, Chen L, Khattar R, et al
    Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
    J Virol. 2016;90:5549-60.
    PubMed     Text format     Abstract available


  119. COWTON VM, Angus AG, Cole SJ, Markopoulou CK, et al
    Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.
    J Virol. 2016 Jun 8. pii: JVI.00685.
    PubMed     Text format     Abstract available


  120. BISWAS A, Treadaway J, Tellinghuisen TL
    Interaction Between Non-Structural Proteins NS4B And NS5A Is Essential For Proper NS5A Localization And Hepatitis C Virus RNA Replication.
    J Virol. 2016 Jun 1. pii: JVI.00037.
    PubMed     Text format     Abstract available


  121. TRAN SC, Pham TM, Nguyen LN, Park EM, et al
    Nonstructural 3 protein of hepatitis C virus modulates tribbles homolog 3/Akt signaling pathway for persistent viral infection.
    J Virol. 2016 Jun 1. pii: JVI.00326.
    PubMed     Text format     Abstract available


  122. BETZ-STABLEIN BD, Topfer A, Littlejohn M, Yuen L, et al
    Single-molecule sequencing reveals complex genomic variation of hepatitis B virus during 15 years of chronic infection following liver transplantation.
    J Virol. 2016 Jun 1. pii: JVI.00243.
    PubMed     Text format     Abstract available


    May 2016
  123. MANKOURI J, Walter C, Stewart H, Bentham M, et al
    Release of infectious hepatitis C virus from Huh7 cells occurs via a trans-Golgi network to endosome pathway independent of VLDL.
    J Virol. 2016 May 25. pii: JVI.00826.
    PubMed     Text format     Abstract available


  124. XUE B, Yang D, Wang J, Xu Y, et al
    ISG12a restricts hepatitis C virus infection through ubiquitination-dependent degradation pathway.
    J Virol. 2016 May 18. pii: JVI.00352.
    PubMed     Text format     Abstract available


  125. BANDIERA S, Pernot S, El Saghire H, Durand SC, et al
    HCV-induced up-regulation of miR-146a-5p in hepatocytes promotes viral infection and deregulates metabolic pathways associated with liver disease pathogenesis.
    J Virol. 2016 May 4. pii: JVI.00619.
    PubMed     Text format     Abstract available


    April 2016
  126. VAN MONTFOORT N, van der Aa E, van den Bosch A, Brouwers H, et al
    Hepatitis B surface antigen activates myeloid dendritic cells via a soluble CD14-dependent mechanism.
    J Virol. 2016 Apr 20. pii: JVI.02903.
    PubMed     Text format     Abstract available


  127. VEGNA S, Gregoire D, Moreau M, Lassus P, et al
    NOD1 participates in the innate immune response triggered by the hepatitis C viral polymerase.
    J Virol. 2016 Apr 20. pii: JVI.03230.
    PubMed     Text format     Abstract available


  128. REN H, Elgner F, Jiang B, Himmelsbach K, et al
    The autophagosomal SNARE protein syntaxin 17 is an essential factor for the hepatitis C virus life cycle.
    J Virol. 2016 Apr 20. pii: JVI.00551.
    PubMed     Text format     Abstract available


  129. LUDGATE L, Liu K, Luckenbaugh L, Streck N, et al
    Cell-free Hepatitis B Virus Capsid Assembly Dependent on Core Protein C-Terminal Domain and Regulated by Phosphorylation.
    J Virol. 2016 Apr 13. pii: JVI.00394.
    PubMed     Text format     Abstract available


  130. KOUWAKI T, Okamoto T, Ito A, Sugiyama Y, et al
    Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx.
    J Virol. 2016;90:3530-42.
    PubMed     Text format     Abstract available


    March 2016
  131. BIEGEL JM, Pager CT
    Hepatitis C Virus Exploitation of Processing Bodies.
    J Virol. 2016 Mar 2. pii: JVI.03056.
    PubMed     Text format     Abstract available


    February 2016
  132. SWANN RE, Cowton VM, Robinson MW, Cole SJ, et al
    Broad anti-HCV antibody responses are associated with improved clinical disease parameters in chronic HCV infection.
    J Virol. 2016 Feb 24. pii: JVI.02669.
    PubMed     Text format     Abstract available


  133. VAN DE GARDE MD, Pas SD, van der Net G, de Man RA, et al
    Hepatitis E virus genotype three infection of human liver chimeric mice as a model for chronic HEV infection.
    J Virol. 2016 Feb 17. pii: JVI.00114.
    PubMed     Text format     Abstract available


  134. LEE EM, Alsagheir A, Wu X, Hammack C, et al
    Hepatitis C virus induced degradation of cell death-inducing DFFA-like effector B leads to hepatic lipid dysregulation.
    J Virol. 2016 Feb 10. pii: JVI.02891.
    PubMed     Text format     Abstract available


  135. LEMPP FA, Qu B, Wang YX, Urban S, et al
    Hepatitis B Virus infection of a mouse hepatic cell line reconstituted with human sodium taurocholate cotransporting polypeptide.
    J Virol. 2016 Feb 10. pii: JVI.02832.
    PubMed     Text format     Abstract available


  136. YIN X, Ambardekar C, Lu Y, Feng Z, et al
    Distinct entry mechanisms for non-enveloped and quasi-enveloped hepatitis E virus.
    J Virol. 2016 Feb 10. pii: JVI.02804.
    PubMed     Text format     Abstract available


  137. VENKATAKRISHNAN B, Katen SP, Francis S, Chirapu S, et al
    Hepatitis B virus capsids have diverse structural responses to small molecule ligands bound to the HAP pocket.
    J Virol. 2016 Feb 3. pii: JVI.03058.
    PubMed     Text format     Abstract available


    January 2016
  138. WASILEWSKI LN, El-Diwany R, Munshaw S, Snider AE, et al
    A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies.
    J Virol. 2016 Jan 27. pii: JVI.02837.
    PubMed     Text format     Abstract available


  139. SANDOMENICO A, Leonardi A, Berisio R, Sanguigno L, et al
    Generation and characterization of monoclonal antibodies against a cyclic variant of Hepatitis C Virus E2 epitope 412-422.
    J Virol. 2016 Jan 27. pii: JVI.02397.
    PubMed     Text format     Abstract available


  140. KONG L, Fujimoto A, Nakamura M, Aoyagi H, et al
    Prolactin regulatory element binding protein is involved in hepatitis C virus replication compartment by interacting with NS4B.
    J Virol. 2016 Jan 6. pii: JVI.01540.
    PubMed     Text format     Abstract available


  141. KECK ZY, Girard-Blanc C, Wang W, Lau P, et al
    Antibody response to the hypervariable region-1 interferes with broadly neutralizing antibodies to hepatitis C virus.
    J Virol. 2016 Jan 6. pii: JVI.02458.
    PubMed     Text format     Abstract available


    December 2015
  142. JIANG B, Himmelsbach K, Ren H, Boller K, et al
    Subviral hepatitis B virus filaments are released like infectious viral particles via multivesicular bodies.
    J Virol. 2015 Dec 30. pii: JVI.03109.
    PubMed     Text format     Abstract available


  143. PALMER BA, Schmidt-Martin D, Dimitrova Z, Skums P, et al
    Network analysis of the chronic Hepatitis C virome defines HVR1 evolutionary phenotypes in the context of humoral immune responses.
    J Virol. 2015 Dec 30. pii: JVI.02995.
    PubMed     Text format     Abstract available


  144. GOMES R, Isken O, Tautz N, McLauchlan J, et al
    Polyprotein driven formation of two interdependent sets of complexes supporting hepatitis C virus genome replication.
    J Virol. 2015 Dec 30. pii: JVI.01931.
    PubMed     Text format     Abstract available


  145. TRAN GV, Luong TT, Park EM, Kim JW, et al
    Nonstructural 5A Protein of Hepatitis C Virus Regulates Soluble Resistance-related Calcium-binding Protein Activity for Viral Propagation.
    J Virol. 2015 Dec 30. pii: JVI.02493.
    PubMed     Text format     Abstract available


  146. JEE MH, Hong KY, Park JH, Lee JS, et al
    A new mechanism of hepatic fibrogenesis: hepatitis C virus infection induces TGF-beta1 production through glucose-regulated protein 94.
    J Virol. 2015 Dec 30. pii: JVI.02976.
    PubMed     Text format     Abstract available


  147. URBANOWICZ RA, McClure CP, Brown RJ, Tsoleridis T, et al
    A diverse panel of Hepatitis C Virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance.
    J Virol. 2015 Dec 23. pii: JVI.02700.
    PubMed     Text format     Abstract available


  148. BASU R, Banerjee K, Bose A, Das Sarma J, et al
    Mouse Hepatitis Virus infection remodels Connexin43 mediated gap junction intercellular communication both in vitro and in vivo.
    J Virol. 2015 Dec 16. pii: JVI.02420.
    PubMed     Text format     Abstract available


  149. YU R, Yang D, Lei S, Wang X, et al
    HMGB1 promotes hepatitis C virus replication by interaction with the stem-loop 4 in viral 5' untranslated region.
    J Virol. 2015 Dec 9. pii: JVI.02795.
    PubMed     Text format     Abstract available


  150. ELSEBAI MF, Koutsoudakis G, Saludes V, Perez-Vilaro G, et al
    Pan-genotypic hepatitis C virus inhibition by natural products derived from the wild Egyptian artichoke.
    J Virol. 2015 Dec 9. pii: JVI.02030.
    PubMed     Text format     Abstract available


  151. WU YL, Peng XE, Zhu YB, Yan XL, et al
    Hepatitis B virus X protein induces hepatic steatosis by enhancing the expression of liver fatty acid binding protein.
    J Virol. 2015 Dec 4. pii: JVI.02604.
    PubMed     Text format     Abstract available


    November 2015
  152. SHRIVASTAVA S, Devhare P, Sujijantarat N, Steele R, et al
    Knockdown of autophagy inhibits infectious hepatitis C virus release by exosomal pathway.
    J Virol. 2015 Nov 18. pii: JVI.02383.
    PubMed     Text format     Abstract available


    October 2015
  153. UCHIDA T, Hiraga N, Imamura M, Tsuge M, et al
    Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice.
    J Virol. 2015;89:10087-96.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: